Overcoming Barriers to Access for Vitiligo Treatment
Experts in dermatological conditions provide insight on challenges patients and clinicians may face in accessing vitiligo medications, especially for newer therapies, and the future of vitiligo treatment.
Assessing Treatment Response in Patients With Vitiligo
Susan C. Taylor, MD, and George Han, MD, PhD, discuss how to measure treatment response in patients with vitiligo and share advice for counseling patients about long-term use and compliance of treatment.
Recent Approvals in Targeted Therapy for Vitiligo
Dr Susan C. Taylor leads a discussion on newly approved agent, ruxolitinib, and its use in clinical practice as a targeted treatment option for patients with vitiligo.
Conventional and Nonconventional Treatment Approaches to Vitiligo
Experts in dermatology comment on treatment approaches to vitiligo, including home phototherapy devices and recent autologous cell-harvesting technology for burn victims.
Patient Education on Expectations for Vitiligo Treatment
Drs Susan C. Taylor and George Han highlight the importance of setting goals, managing patient expectations, and shared-decision making for vitiligo treatment.
Initiating Patient Conversations on Vitiligo Diagnosis and QoL
Susan C. Taylor, MD, leads a discussion on approaching patient conversations on vitiligo including understanding patient lifestyle, cultural impact, and the impact on QoL.
Differentiating Vitiligo From Other Hypopigmentation Skin Conditions
Experts in dermatological conditions review the different types of vitiligo and comment on distinguishing features that may be affected as well as differentiating from other hypopigmentation skin conditions.
Overview of Vitiligo: Patient Demographics and Etiology
Susan C. Taylor, MD, and George Han, MD, PhD, provide insight on disease awareness for vitiligo, patient demographics, and factors that contribute to vitiligo etiology.
2 Clarke Drive Cranbury, NJ 08512